Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
BIBProSharesINDEX

ProShares Ultra Nasdaq Biotechnology

$115.27+3.79% vs prior close
6812652-WK

Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 26, 2026. Holdings snapshot retrieved Oct 26, 2026.

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

BIB price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateBIB close
Sep 28, 2026$115.63
Sep 29, 2026$115.88
Sep 30, 2026$115.45
Oct 1, 2026$110.47
Oct 2, 2026$109.80
Oct 5, 2026$112.06
Oct 6, 2026$106.90
Oct 7, 2026$107.46
Oct 8, 2026$105.02
Oct 9, 2026$110.98
Oct 12, 2026$108.79
Oct 13, 2026$103.59
Oct 14, 2026$106.82
Oct 15, 2026$111.11
Oct 16, 2026$105.10
Oct 19, 2026$107.09
Oct 20, 2026$113.95
Oct 21, 2026$114.71
Oct 22, 2026$112.85
Oct 23, 2026$110.32
Oct 26, 2026$111.07
Oct 27, 2026$115.27

Daily net flows, 1M

Net inflow over the range: +$2M

  • Inflow / above zero
  • Outflow / below zero
Sep 28Sep 30Oct 2Oct 6Oct 8Oct 12Oct 14Oct 16Oct 20+$2.3MOct 22$0Oct 26Sep 28Sep 30Oct 2Oct 6Oct 8Oct 12Oct 14Oct 16Oct 20+$2.3MOct 22$0Oct 26Sep 28Oct 2Oct 8Oct 14Oct 20+$2.3M$0Oct 26
Source: Daily creation and redemption records
Show as table
LabelValue ($)
Sep 28$0
Sep 29$0
Sep 30$0
Oct 1$0
Oct 2$0
Oct 5$0
Oct 6$0
Oct 7$0
Oct 8$0
Oct 9$0
Oct 12$0
Oct 13$0
Oct 14$0
Oct 15$0
Oct 16$0
Oct 19$0
Oct 20$0
Oct 21$0
Oct 22$2.3M
Oct 23$0
Oct 26$0
The desk’s read

Money keeps arriving — +$2M of net inflows over the past month, about 2.4% of the fund's asset base, while the price has returned +44.5% so far this year. At 0.95% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$96Massets under management
0.95%expense ratio · $95 per $10,000 a year
+$2Mnet flow, trailing month
8Kavg daily volume, 30 days
229holdings · US-domiciled
2010listed April 9, 2010 · beta 1.55

Sector weights

  • Healthcare100%
  • Other72.51%
  • Health Technology69.19%
  • Cash29.28%
  • Commercial Services1.36%
  • Health Services0.16%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Other72.51%
Health Technology69.19%
Cash29.28%
Commercial Services1.36%
Health Services0.16%

Country weights

  • United States88.94%
  • Other69.75%
  • United Kingdom5.32%
  • France1.49%
  • Germany0.9%
  • China0.89%
  • Denmark0.86%
  • Switzerland0.45%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States88.94%
Other69.75%
United Kingdom5.32%
France1.49%
Germany0.9%
China0.89%
Denmark0.86%
Switzerland0.45%
Performance
1 week+0.5%
1 month+0.7%
3 months+16.9%
6 months+39.4%
YTD+44.5%
1 year+66.9%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week+$2M
1 month+$2M
3 months+$3M
YTD−$14M
1 year−$8M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows

  • Inflow / above zero
  • Outflow / below zero
+$6MNov+$10KDec−$40KJan−$890KFeb−$4MMar−$5.1MApr−$4.8MMay−$3.6MJun−$1.9MJul+$7MAug−$3.3MSep+$2.3MOct+$6MNov+$10KDec−$40KJan−$890KFeb−$4MMar−$5.1MApr−$4.8MMay−$3.6MJun−$1.9MJul+$7MAug−$3.3MSep+$2.3MOctNovJanMarMayJul+$7M+$2.3MOct
Source: Daily creation/redemption records, trailing twelve months
Show as table
LabelValue ($)
Nov$6M
Dec$10K
Jan−$40K
Feb−$890K
Mar−$4M
Apr−$5.1M
May−$4.8M
Jun−$3.6M
Jul−$1.9M
Aug$7M
Sep−$3.3M
Oct$2.3M
The risk read
54%realized volatility, 30 days (annualized)
45%realized volatility, 1 year
-17.9%deepest fall from a peak, 1 year
-8.7%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
1calls · latest snapshot
—puts · latest snapshot
—put/call ratio
3Kshares traded
The case against BIB

Due diligence cuts both ways. These funds sit on the same shelf and beat BIB on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$40.7B+$609M-92bp on fee · 426× the assets · +$609M in over the monthHead-to-head
BBUS JPMorgan BetaBuilders U.S. Equity ETF0.02%$9.6B+$187M-93bp on fee · 100× the assets · +$187M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-92bp on fee · 192× the assets · +$199M in over the monthHead-to-head
SPYG State Street SPDR Portfolio S&P 500 Growth ETF0.04%$57.9B+$717M-91bp on fee · 605× the assets · +$717M in over the monthHead-to-head
SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.03%$14.2B+$235M-92bp on fee · 149× the assets · +$235M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.